Clene News

IBN Coverage: Clene (NASDAQ: CLNN) Makes Strides in Developing CNM-Au8(R) to Address Neurodegenerative Conditions

Yahoo FinanceAug 13 12:47 ET

IBN Coverage: Clene (NASDAQ: CLNN) CEO Spotlighted in Recent BioMedWire Podcast Episode

Yahoo FinanceAug 12 08:00 ET

HC Wainwright & Co. Maintains Buy on Clene, Adjusts Price Target To $31

Analyst UpgradesAug 9 17:40 ET

HC Wainwright & Co. Maintains Buy on Clene, Adjusts Price Target To $31 (1-20 Reverse Stock Split)

BenzingaAug 9 17:40 ET · Ratings

IBN Coverage: Clene (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates

Yahoo FinanceAug 9 09:00 ET

Buy Rating Justified for Clene Amidst Promising ALS Trial Results and Potential Accelerated FDA Approval

TipRanksAug 8 12:16 ET · Ratings

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Rob Etherington, CEO of Clene Inc.

Globe NewswireAug 8 08:00 ET

Express News | Ibn Announces Latest Episode of the Biomedwire Podcast Featuring Rob Etherington, CEO of Clene Inc.

ReutersAug 8 08:00 ET

Clene Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Revenue Results.

BenzingaAug 7 12:44 ET

Clene GAAP EPS of -$1.06, Revenue of $0.09M

Seeking AlphaAug 7 09:41 ET

Express News | Clene Q2 2024 Adj EPS $(1.06) Beats $(1.49) Estimate, Sales $91.00K Miss $100.00K Estimate

BenzingaAug 7 08:27 ET

Earnings Flash (CLNN) CLENE Reports Q2 Revenue $91,000

MT NewswiresAug 7 08:25 ET

Express News | Clene Reports Second Quarter 2024 Financial Results and Recent Operating Highlights

ReutersAug 7 08:23 ET

Clene 2Q Loss/Shr $1.06 >CLNN

Dow JonesAug 7 08:23 ET

Express News | Clene Inc.- Qtrly Shr Loss $1.06

ReutersAug 7 08:13 ET

Optimistic Outlook for Clene's CNM-Au8 ALS Treatment Backed by Positive FDA Submission Data

TipRanksAug 7 07:30 ET

10-Q: Q2 2024 Earnings Report

SEC announcementAug 7 07:06 ET · Announcements

Clene Closes Higher After Submitting Additional Data Supporting Prospective ALS Treatment

MT NewswiresAug 6 16:18 ET

Express News | Canaccord Genuity Reiterates Buy on Clene, Maintains $94 Price Target

BenzingaAug 6 10:10 ET

Clene Analyst Ratings

BenzingaAug 6 10:06 ET · Ratings